9:00 am – 9:30 am
10th May
Maximilian Stahl, M.D.
Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA
9:30 am – 10:00 am
10th May
Yogen Sauthararajah, M.D.
Taussig Cancer Institute, Cleveland Clinic, USA
10:00 am – 10:30 am
10th May
Eva Hellström Lindberg, M.D., Ph.D.
Karolinska Institutet, Stockholm, Sweden
10:30 am – 11:00 am
10th May
William Brian Dalton, M.D., Ph.D.
11:00 am – 11:30 am
10th May
Abbvie Farhad Ravandi-Kashani, M.D.
University of Texas MD Anderson Cancer Center, Houston, USA
11:30 am – 12:10 am
10th May
Johnson & Johnson Innovative Medicine Symposium
Mihaela Cornelia Lazaroiu M.D.
Title: Optimal treatment sequencing in multiple myeloma
Ciprian Tomuleasa M.D.
Department of Hematology – Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Title: Redirecting treatment strategies in MMRR
12:10 pm – 1:00 pm
10th May
Lunch
1:00 pm -1:30 pm
10th May
Jonathan Fromm, MD
Department of Laboratory Medicine and Pathology, University of Washington.
1:30 pm – 2:00 pm
10th May
Olafur Eysteinn Sigurjonsson, Ph.D.
School of Science and Engineering, Reykjavik University, Iceland
2:00 pm – 2:15 pm
10th May
BMS Symposium
Bogdan Ionescu M.D.
Fundeni Clinical Institute, Bucharest, Romania
Title: ONUREG – The journey of AML patients in remission goes on
2:15 pm – 2:45 pm
10th May
AstraZeneca Symposium
Expand your PNH&aHUS patients horizon
Moderator: Mihnea Zdrenghea M.D.
Hematologist, Oncological Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca
- “PNH Diagnosis: When to test? Whom to test?”
- “Are your patients at risk? Defining aHUS” – Prof Dr Ina Kacso
Ina Kacso M.D.
MD, PhD, Professor of Nephrology at the University of Medicine and Pharmacy “Iuliu Hatieganu” Cluj and Head of the Department of Nephrology of the Emergency Conty Hospital Cluj, current President of the Romanian Society of Nephrology. Main interest in glomerular disease and pathogenic mechanisms in diabetic and non-diabetic CKD.”
2:45 pm – 3:15 pm
10th May
AstraZeneca Symposium
Horia Bumbea M.D., Ph.D.
Next generation BTKi in CLL treatment
3:15 pm – 4:00 pm
10th May
Genesis Pharma Symposium “Updates in the management of Acute Hepatic Porphyria and hATTR Amyloidosis”
Moderator: Mihnea Zdrenghea M.D.
Hematologist, Oncological Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca
Presentations’ titles:
– “A new perspective in hATTR Amyloidosis management”
Ioana Codruţa Rus M.D.
Hematolog, Institutul Oncologic “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca
– “Clinical Evidences in hATTR treatment”
Tőrők-Vistai Tünde M.D.
Hematolog, Institutul Oncologic “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca
– “Porfiria Acuta Hepatica. From scientific evidence to clinical experience”
Ciprian Tomuleasa M.D.
Hematologist, Oncological Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca
4:00m – 4:20 pm
10th May
Roche Symposium
Ciprian Tomuleasa, M.D.
Department of Hematology – Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Mihnea Zdrenghea M.D.
Department of Hematology – Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
4:20m – 4:40 pm
10th May
Sanofi Symposium
Ciprian Tomuleasa, M.D.
Department of Hematology – Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
4:40m – 5:10 pm
10th May
Recordati Rare Diseases Symposium | Castleman disease
Maria Bouzani M.D., Ph.D.
Title: Real-world experience from Greece
Ciprian Tomuleasa, M.D.
Department of Hematology – Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Title: Real-world experience from Romania
5:10m – 5:30 pm
10th May
Pfizer Symposium
Mihnea Zdrenghea M.D.
Title: MYLOTARG® (gemtuzumab ozogamicin): Essential in first-line treatment in AML
5:30m – 5:50 pm
10th May
Pfizer Symposium
Alina Tanase M.D.
Title: BESPONSA® (inotuzumab ozogamicin): Personalizing Treatment in R/R ALL: First Choice Matters
5:50m – 6:10 pm
10th May
Pfizer Symposium
Ciprian Tomuleasa, M.D.
Department of Hematology – Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Title: ReFacto® AF: experience in the management of hemophilia A
6:10m – 6:40 pm
10th May
Eli Lilly Symposium
Horia Bumbea M.D., Ph.D.
Ciprian Tomuleasa, M.D.
Department of Hematology – Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Title: Recent Progress in Mantle Cell Lymphoma
